AU Patent

AU2003237224A1 — 1,2 diamido cycloalkyl sodium channel blockers

Assigned to Merck and Co Inc · Expires 2003-12-19 · 22y expired

What this patent protects

Patent listed against Journavx.

Drugs covered by this patent

Journavx (SUZETRIGINE) · Vertex Pharms Inc

Patent Metadata

Patent number: AU2003237224A1
Jurisdiction: AU
Classification: —
Expires: 2003-12-19
Drug substance claim: No
Drug product claim: No
Assignee: Merck and Co Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.